Article Details
Retrieved on: 2022-09-26 11:03:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today ...
Article found on: www.newswire.ca
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here